CSI Market
Sign In | Register

Esperion Therapeutics Inc (ESPR) Annual Balance Sheets

Annual · GAAP · USD millions
Access ESPR quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Esperion Therapeutics Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ESPR/balance-sheets
https://api.csimarket.com/api/v1/companies/ESPR/fundamentals
https://api.csimarket.com/api/v1/companies/ESPR/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent167.85
Short-term Investments, Total0.00
Cash & Short-term Investments167.00
Accounts receivable140.19
Inventories105.12
Other Current Assets44.91
Prepaid Expense And Other Assets Current4.50
Total Current Assets462.57
Equipment/Property/Plant Net0.34
Intangible Assets0.06
Other Assets, Noncurrent0.00
Prepaid Clinical Development Costs Current4.04
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset2.92
Total Assets465.89
Liabilities
Accounts Payable, Current AC65.07
Other Accrued Liabilities, Current0.00
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current235.74
Total Current Liabilities300.81
Other Long-term Debt, Noncurrent OT152.22
Convertible Notes Payable, Noncurrent LO97.26
Total Long-term Debt249.48
Other liabilities, Noncurrent217.56
Accrued Clinical Development Costs Current4.12
Contract With Customer Liability Current34.48
Operating Lease Liability Current2.10
Revenue Interest Liability Noncurrent-
Operating Lease Liability Noncurrent0.65
Total Liabilities767.85
Stockholders' Equity
Treasury Stock Common Value-55.00
Common Stock Value0.25
Treasury Stock Value0.00
Additional Paid In Capital Common Stock1,376.50
Retained Earnings / Accumulated Deficit-1,623.71
Other Equity0.00
Common Stockholder's Equity-301.97
Total Stockholder's Equity-301.97
Liabilities & Stockholder's Equity465.89
4 historic quarters locked

Sign in to unlock the full Esperion Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Esperion Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-016522

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI